FLAVOXATE

FLAVOXATE Basic information
Product Name:FLAVOXATE
Synonyms:FLAVOXATE;2-(1-Piperidinyl)ethyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate;2-Piperidinoethyl 3-methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylate;4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-piperidinyl)ethyl ester;3-Methyl-4-oxo-2-phenyl-4H-1-benzopyran-8-carboxylic acid 2-piperidinoethyl ester;Piperidinoethyl 3-methyl-2-phenyl-4-oxo-4H-1-benzopyran-8-carboxylate;2-(Piperidin-1-yl)ethyl 3-Methyl-4-oxo-2-phenyl-4H-chroMene-8-carboxylate;Flavoxate-d5
CAS:15301-69-6
MF:C24H25NO4
MW:391.46
EINECS:239-337-5
Product Categories:
Mol File:15301-69-6.mol
FLAVOXATE Structure
FLAVOXATE Chemical Properties
Melting point 87-88 °C
Boiling point 564.1±50.0 °C(Predicted)
density 1.203±0.06 g/cm3(Predicted)
form Off-white solid.
pka7.3(at 25℃)
CAS DataBase Reference15301-69-6(CAS DataBase Reference)
Safety Information
ToxicityLD50 in rats (mg/kg): 1110 orally; 20.8 i.v. (Setnikar, 1975)
MSDS Information
FLAVOXATE Usage And Synthesis
OriginatorUrispas,SKF,US,1971
UsesFlavoxate is a pharmaceutical active-containing film delivery device for oral transmucosal administration.
UsesRelaxant (smooth muscle).
DefinitionChEBI: A carboxylic ester resulting from the formal condensation of 3-methylflavone-8-carboxylic acid with 2-(1-piperidinyl)ethanol.
Manufacturing ProcessA mixture of 13.3 grams of anhydrous aluminum chloride and 100 ml of carbon disulfide is added to 19.4 grams of 2-propionyloxybenzoic acid (prepared from the reaction of propionyl chloride and 2-hydroxybenzoic acid). After an initial evolution of hydrogen chloride, the solvent is removed by distillation and the mixture is heated at 150° to 160°C for 4 hours. The cooled reaction mixture is treated with ice and hydrochloric acid and the product, 2- hydroxy-3-carboxypropiophenone, is obtained from the oily residue by distillation in vacuo.
A mixture of 1.9 grams of 2-hydroxy-3-carboxypropiophenone, 5.0 grams of sodium benzoate and 20.0 grams of benzoic anhydride is heated at 180° to 190°C for 6 hours. A solution of 15.0 grams of potassium hydroxide in 50 ml of ethanol and 20 ml of water is added and refluxed for 1 hour. The mixture is evaporated and the residue after addition of water yields 3-methylflavone-8- carboxylic acid.
To a suspension of 12.0 grams of 3-methylflavone-8-carboxylic acid in 200 ml of anhydrous benzene is added 10.0 grams of thionyl chloride. The mixture is refluxed for 2 hours during which the suspended solid goes into solution. The solvent is completely removed by distillation, the residue extracted with benzene and the extract evaporated to dryness. The product, 3- methylflavone-8-carboxylic acid chloride, is recrystallized from ligroin to give crystals melting at 155° to 156°C.
To 11.0 grams of 3-methylflavone-8-carboxylic acid chloride dissolved in 150 ml of anhydrous benzene is added at room temperature 4.8 grams of piperidinoethanol and the mixture refluxed for 2 to 3 hours. The separated solid is filtered, washed with benzene and dried. The product, piperidinoethyl 3-methylflavone-8-carboxylate hydrochloride is obtained as a colorless crystalline solid, MP 232° to 234°C, (from US Patent 2,921,070).


Brand nameUrispas (Ortho-McNeil).
Therapeutic FunctionSpasmolytic
FLAVOXATE Preparation Products And Raw materials
Raw materials2-Piperidinoethanol-->Propionyl chloride-->Benzoic anhydride-->Thionyl chloride-->Aluminum chloride-->Salicylic acid
Pentoxifylline L-Glutamine Aristoforin SAFFLOWER YELLOW Vincamine Tizanidine Terflavoxate FLAVOXATE FLAVOXATE HCL,FLAVOXATE HYDROCHLORIDE FLAVOXATE HYDROCHLORIDE (FAD) Flavoxate impurity A 4H-1-Benzopyran-8-carboxylic acid, 3-methyl-4-oxo-2-phenyl-, 2-(1-pipe ridinyl)cyclohexyl ester, hydrochloride, trans-(+-)- Flavoxate impurity B 3-Quinuclidinyl 3-methylflavone-8-carboxylate hydrochloride

Email:[email protected] [email protected]
Copyright © 2024 Mywellwork.com All rights reserved.